The ASH Research Collaborative COVID-19 Registry for Hematology provides up-to-date information on outcomes and the course of illness for a group of patients with hematologic malignancies and COVID-19.1 In general, registry data showed that hematologic malignancies increase the risk of severity of COVID-19 and associated…
A study that included nearly 2.5 million children born in Sweden found the risk of ALL was 21% higher in children born by planned cesarean…
A common germline variant in the proprotein convertase subtilisin/kexin type 9 (PCSK9) (rs562556, V474I) gene rather than a mutation in a breast cancer tumor may…
Over the past 20 years, increased understanding of the biological mechanism of disease has led to improved treatment options for all malignancies. Within each disease…
Childhood cancer survivors had a lower risk of contracting COVID-19 but were 58% more likely to develop severe disease if they did become infected, according…
In a phase II trial reported in The Lancet Oncology, Elimova et al evaluated the efficacy and safety of zanidatamab plus chemotherapy in the first-line…
A study led by researchers at the American Cancer Society has found that after the introduction of immune checkpoint inhibitors in 2011, there was a…
In a Spanish-French phase II trial (SPOTLIGHT-203) reported in the Journal of Clinical Oncology, Márquez-Rodas et al investigated the combination of the intratumoral agent BO-112…
On November 9, the U.S. Food and Drug Administration (FDA) approved ADAMTS13, recombinant-krhn (Adzynma), the first genetically engineered protein… On November 7, the U.S. Food…
The expanded indication marks the first and only radioembolization therapy in the United States approved to treat both unresectable hepatocellular carcinoma (HCC) and colorectal cancer liver metastase…
Investigators have examined the association between alcohol consumption and the risk of developing pancreatic cancer.
